{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:56:27Z","timestamp":1786992987006,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jneuroim.2022.577820","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T19:51:59Z","timestamp":1643485919000},"page":"577820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome"],"prefix":"10.1016","volume":"365","author":[{"given":"Kamel","family":"Hamzaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Borhani-Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imen Ben","family":"Dhifallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jneuroim.2022.577820_bb0005","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jcp.27207","article-title":"Disturbed Th17\/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet\u2019s disease","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577820_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","article-title":"Interleukin-6 in neuro-Beh\u00e7et\u2019s disease: association with disease subsets and long-term outcome","volume":"44","author":"Akman-Demir","year":"2008","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","article-title":"Neuro-Beh\u00e7et\u2019s disease: epidemiology, clinical characteristics, and management","volume":"8","author":"Al-Araji","year":"2009","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577820_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/BOR.0000000000000497","article-title":"Management of Beh\u00e7et\u2019s disease","volume":"30","author":"Alibaz-Oner","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577820_bb0025","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/1346-8138.13381","article-title":"Beh\u00e7et\u2019s disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions","volume":"43","author":"Alpsoy","year":"2016","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577820_bb0035","first-page":"170","article-title":"The cerebrospinal fluid presentations of neuro-Bechet disease, a way to know the etiopathogenesis and improve armamentarium","volume":"18","author":"Banerjee","year":"2021","journal-title":"Iran J. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-9-23","article-title":"TNF-\u03b1 protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation","volume":"9","author":"Belarbi","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2022.577820_bb0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cyto.2018.03.039","article-title":"Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Beh\u00e7et disease","volume":"108","author":"Belghith","year":"2018","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577820_bb0050","first-page":"299","article-title":"Decreased level of IL-37 correlates negatively with inflammatory cytokines in cerebrospinal fluid of patients with neuro-Behcet\u2019s disease","volume":"16","author":"Ben Dhifallah","year":"2019","journal-title":"Iran. J. Immunol."},{"issue":"38","key":"10.1016\/j.jneuroim.2022.577820_bb0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","article-title":"Beh\u00e7et\u2019s disease: evaluation of a new instrument to measure clinical activity","volume":"1999","author":"Bhakta","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.jneuroim.2022.577820_bb0060","doi-asserted-by":"crossref","first-page":"101906","DOI":"10.1016\/j.msard.2019.101906","article-title":"Neuro-Behcet\u2019s disease: An update on diagnosis, differential diagnoses, and treatment","volume":"39","author":"Borhani-Haghighi","year":"2019","journal-title":"Multiple Scler. Related Disord."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.imlet.2015.08.001","article-title":"Interleukin-37 expression is decreased in Beh\u00e7et\u2019s disease and is associated with inflammation","volume":"167","author":"Bouali","year":"2015","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0070","doi-asserted-by":"crossref","first-page":"8453","DOI":"10.1038\/s41598-017-09164-7","article-title":"Mutational profile of rare variants in inflammasome-related genes in Beh\u00e7et disease: a next generation sequencing approach","volume":"7","author":"Burillo-Sanz","year":"2017","journal-title":"Sci. Rep."},{"issue":"Pt B","key":"10.1016\/j.jneuroim.2022.577820_bb0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbr.2016.08.027","article-title":"Neuroinflammatory challenges compromise neuronal function in the aging brain: postoperative cognitive delirium and Alzheimer\u2019s disease","volume":"322","author":"Cortese","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","article-title":"Identification of a novel gene expressed in activated natural killer cells and T cells","volume":"148","author":"Dahl","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0085","doi-asserted-by":"crossref","first-page":"14050","DOI":"10.1038\/s41598-018-32485-0","article-title":"Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients","volume":"8","author":"Damen","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Behcet\u2019s disease: epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"Davatchi","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13012","article-title":"The role of Interleukin-32 in autoimmunity","volume":"93","author":"de Albuquerque","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","article-title":"Neurodegenerative diseases and oxidative stress","volume":"58","author":"Emerit","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab253","article-title":"Regulatory T cell\/Th17 balance in the pathogenesis of pediatric Beh\u00e7et disease","author":"Filleron","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"issue":"12","key":"10.1016\/j.jneuroim.2022.577820_bb0110","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.3390\/ijms21124223","article-title":"Focus on the role of NLRP3 inflammasome in diseases","volume":"21","author":"Fusco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2021.04.008","article-title":"Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet\u2019s disease","volume":"235","author":"Gelmez","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0120","doi-asserted-by":"crossref","first-page":"110158","DOI":"10.1016\/j.mehy.2020.110158","article-title":"Interleukin 32: a novel player in perioperative neurocognitive disorders","volume":"144","author":"Gong","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577820_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","article-title":"Beh\u00e7et\u2019s disease: new insights into pathophysiology, clinical features and treatment options","volume":"17","author":"Greco","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2022.577820_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneuroim.2011.01.012","article-title":"RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Beh\u00e7et\u2019s disease","volume":"233","author":"Hamzaoui","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577820_bb0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/cmi.2014.31","article-title":"Increased interleukin 33 in patients with neuro-Behcet's disease: correlation with MCP-1 and IP- 10 chemokines","volume":"11","author":"Hamzaoui","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2022.577820_bb0160","first-page":"9","article-title":"The international classification of headache disorders: 2nd edition","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia Int. J. Headache"},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577820_bb0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/ard.2010.139196","article-title":"Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade","volume":"70","author":"Heinhuis","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"24","key":"10.1016\/j.jneuroim.2022.577820_bb0170","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.2169\/internalmedicine.51.8583","article-title":"Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Beh\u00e7et's disease","volume":"51","author":"Hirohata","year":"2012","journal-title":"Int. Med."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2022.577820_bb0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2015.01.005","article-title":"Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet\u2019s disease","volume":"349","author":"Hirohata","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5692\/clinicalneurol.cn-001238","volume":"59","author":"Hisanaga","year":"2019","journal-title":"Rinsho shinkeigaku Clinical neurology"},{"issue":"26","key":"10.1016\/j.jneuroim.2022.577820_bb0185","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1073\/pnas.1201836109","article-title":"NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis","volume":"109","author":"Inoue","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","article-title":"Immunosuppression for the Uveitides","volume":"125","author":"Jabs","year":"2018","journal-title":"Ophthalmology"},{"issue":"47","key":"10.1016\/j.jneuroim.2022.577820_bb0195","doi-asserted-by":"crossref","first-page":"15811","DOI":"10.1523\/JNEUROSCI.4088-10.2010","article-title":"The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18","volume":"30","author":"Jha","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.imlet.2017.08.008","article-title":"Interleukin-26 is overexpressed in Beh\u00e7et\u2019s disease and enhances Th17 related-cytokines","volume":"190","author":"Kaabachi","year":"2017","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.jneuroim.2022.577820_bb0205","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of neuro-Beh\u00e7et\u2019s disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577820_bb0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.humimm.2006.12.006","article-title":"Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet\u2019s disease","volume":"68","author":"Kamoun","year":"2007","journal-title":"Hum. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2022.577820_bb0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","article-title":"Effect of infliximab in progressive neuro- Beh\u00e7et\u2019s syndrome","volume":"272","author":"Kikuchi","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0220","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNF alpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2022.577820_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12950-015-0086-z","article-title":"Increased expression of the NLRP3 inflammasome components in patients with Beh\u00e7et\u2019s disease","volume":"12","author":"Kim","year":"2015","journal-title":"J. Inflam."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0230","doi-asserted-by":"crossref","first-page":"102421","DOI":"10.1016\/j.jaut.2020.102421","article-title":"Systemic autoinflammatory diseases","volume":"109","author":"Krainer","year":"2020","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2- decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Behcet\u2019s disease activity index","volume":"43","author":"Lawton","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2022.577820_bb0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Beh\u00e7et\u2019s disease activity index","volume":"43","author":"Lawtong","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.jneuroim.2022.577820_bb0250","doi-asserted-by":"crossref","first-page":"20098","DOI":"10.1038\/srep20098","article-title":"Genetic variations of NLR family genes in Behcet\u2019s disease","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577820_bb0255","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1167\/iovs.12-11047","article-title":"IL-1\u03b2 triggered by peptidoglycan and lipopolysaccharide through TLR2\/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Beh\u00e7et\u2019s disease","volume":"54","author":"Liang","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577820_bb0260","doi-asserted-by":"crossref","first-page":"R246","DOI":"10.1186\/ar4089","article-title":"IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis","volume":"14","author":"Moon","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0265","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jns.2017.05.045","article-title":"Association between interleukin-32 polymorphism and multiple sclerosis","volume":"379","author":"Morsaljahan","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jneuroim.2022.577820_bb0270","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00415-011-6036-7","article-title":"Elevated serum level of interleukin-32\u03b1 in the patients with myasthenia gravis","volume":"258","author":"Na","year":"2011","journal-title":"J. Neurol."},{"issue":"45","key":"10.1016\/j.jneuroim.2022.577820_bb0275","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","article-title":"IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism","volume":"102","author":"Netea","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577820_bb0280","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3899\/jrheum.140949","article-title":"Variants of the IFI16 gene affecting the levels of expression of mRNA are associated with susceptibility to Beh\u00e7et disease","volume":"42","author":"Ortiz-Fern\u00e1ndez","year":"2015","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.jneuroim.2022.577820_bb0285","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1468-3083.2010.03941.x","article-title":"2011. Serum galectin-3 levels in patients with Beh\u00e7et\u2019s disease: association with disease activity over a long-term follow-up","volume":"25","author":"\u00d6zden","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"12\u221213","key":"10.1016\/j.jneuroim.2022.577820_bb0290","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.molimm.2011.03.012","article-title":"Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-\u03baB","volume":"48","author":"Pan","year":"2011","journal-title":"Mol. Immunol."},{"issue":"4 Suppl 45","key":"10.1016\/j.jneuroim.2022.577820_bb0295","first-page":"S34","article-title":"Dendritic cell subsets and type I interferon system in Beh\u00e7et\u2019s disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?","volume":"25","author":"Pay","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0300","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.jneuroim.2022.577820_bb0305","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/jnnp.2004.055434","article-title":"Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Beh\u00e7et disease","volume":"76","author":"Ribi","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2022.577820_bb0310","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","article-title":"Cytokines and chemokines in neuro-Beh\u00e7et\u2019s disease compared to multiple sclerosis and other neurological diseases","volume":"145","author":"Saruhan-Direskeneli","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2022.577820_bb0315","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/kes399","article-title":"Pro-inflammatory cytokine and caspase-1 responses to pattern recognition receptor activation of neutrophils and dendritic cells in Behcet\u2019s disease","volume":"52","author":"T\u00fcre-\u00d6zdemir","year":"2013","journal-title":"Rheumatology (Oxford, England)"},{"issue":"12","key":"10.1016\/j.jneuroim.2022.577820_bb0320","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.4049\/jimmunol.1002306","article-title":"Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1","volume":"186","author":"Turner-Brannen","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jneuroim.2022.577820_bb0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11910-018-0843-5","article-title":"Beh\u00e7et\u2019s syndrome and nervous system involvement","volume":"18","author":"Uyguno\u011flu","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117436","article-title":"An uncommon disease included commonly in the differential diagnosis of neurological diseases: neuro-Beh\u00e7et\u2019s syndrome","volume":"426","author":"Uyguno\u011flu","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577820_bb0335","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10875-012-9837-2","article-title":"Increased plasma interleukin-32 expression in patients with neuromyelitis optica","volume":"33","author":"Wang","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0340","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.08570814","article-title":"Immunosuppressive medications","volume":"11","author":"Wiseman","year":"2016","journal-title":"CJASN"},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0345","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Beh\u00e7et syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577820_bb0350","doi-asserted-by":"crossref","first-page":"20401","DOI":"10.1038\/srep20401","article-title":"Decreased B and T lymphocyte attenuator in Behcet\u2019s disease may trigger abnormal Th17 and Th1 immune responses","volume":"4","author":"Ye","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jneuroim.2022.577820_bb0355","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/intimm\/dxt046","article-title":"Novel NLRP3\/cryopyrin mutations and pro-inflammatory cytokine profiles in Beh\u00e7et\u2019s syndrome patients","volume":"26","author":"Y\u00fcksel","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577820_bb0360","article-title":"The efficacy and safety of anti-TNF agents in the treatment of intestinal Behcet\u2019s disease, a systematic review and meta-analysis","author":"Zhang","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577820_bb0365","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3892\/mmr.2021.11865","article-title":"IL-32 exacerbates adenoid hypertrophy via activating NLRP3-mediated cell pyroptosis, which promotes inflammation","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:40:10Z","timestamp":1759048810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":68,"alternative-id":["S0165572822000157"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577820","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577820"}}